Cardiex launches industry-first at-home heart report

Cardiex has launched a Cardiology Report feature in its CONNEQT app, to give consumers clinical-grade heart health insights at home.

Pic via Getty Images

• Cardiex launches Cardiology Report in CONNEQT app to deliver clinical-grade heart insights to consumers

• New feature enhances at-home monitoring, translating advanced cardiovascular biomarkers into intuitive reports for patients and physicians

• The report is expected to significantly increase user engagement, expand the company’s health data ecosystem and fuel future growth through subscriptions

Special report: ASX-listed medtech innovator Cardiex has launched a new Cardiology Report feature within its CONNEQT app, marking a major milestone in the company’s consumer health strategy.

Drawing on more than two decades of clinical research, the feature delivers personalised insights into heart and arterial health, translating complex vascular biomarkers into intuitive reports that users can understand and share with their doctors.

Designed to support proactive heart health management, the Cardiology Report enables users to track key metrics over time, detect early risk factors and make better-informed lifestyle or treatment decisions in consultation with healthcare professionals.

“The launch of the Cardiology Report marks an important milestone in our mission to deliver clinical-grade heart health insights directly to consumers,” said Cardiex (ASX:CDX) CEO Craig Cooper.

“We’re enabling individuals to proactively manage their cardiovascular health beyond the confines of the clinic.”

Turning clinical insight into daily action

The Cardiology Report feature builds on data captured by Cardiex’s FDA-cleared CONNEQT Pulse, a state-of-the-art arterial health monitor. It provides users with a holistic snapshot of their cardiovascular system, including central blood pressure, arterial stiffness, and other advanced metrics increasingly seen as more predictive of heart risk than traditional arm-cuff readings.

By offering these insights in a visually accessible and consumer-friendly format, Cardiex is helping to bridge a longstanding gap between clinical diagnostics and everyday health awareness.

Fuelling engagement and revenue growth

The new feature is also designed to drive long-term engagement within the CONNEQT app, encouraging users to return for ongoing assessments and trend tracking. It also lays the groundwork for future monetisation via premium features, subscription-based guided health programs and deeper trend analytics.

With cardiovascular disease remaining the world’s number one killer, Cardiex CEO Craig Cooper said the company’s push to empower consumers with better data and earlier insights is particularly timely.

“With growing demand for tools that support heart health monitoring at home, this feature directly meets that need,” he said.

“More broadly, it strengthens the CONNEQT app’s role as a central hub for personalised cardiovascular insights and further solidifies Cardiex’s leadership in the digital transformation of heart health.”

A broader vision for consumer cardiovascular tech

Cardiex has been steadily gaining traction in the global digital health sector, bolstered by the recent US launch of the CONNEQT Pulse monitor and successful capital raises to support scaling.

The announcement continues a strong 12 months for the company, which includes a $3.25 million capital raise to scale production of the CONNEQT Pulse device and meet accelerating US demand and the device’s inclusion on the US Blood Pressure Validated Device Listing – a key clinical endorsement for accuracy and reliability.

This article was developed in collaboration with Cardiex, a Stockhead advertiser at the time of publishing.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.